Other Streetwise ReportsThe Gold Report The Energy Report The Life Sciences Report The Mining Report
Today's Featured Company
Cellular Biomedicine Group Inc.: (CBMG:NASDAQ) Addressing unmet medical needs of the world’s largest population, Cellular Biomedicine Group is a biomedicine firm engaged in the development of effective cellular therapies for degenerative joint diseases and airway diseases, immuno-oncology drugs for various cancers, as well as providing biomedical and cellular technical services to healthcare facilities in China. More >
Streetwise Expert Interviews
Medical technology is not considered a huge-margin investment in the way that the biotech and drug industries are. However, some of today's medtech blurs the line, including hybrid companies developing stem cell and drug-device delivery systems that address complex disease indications ranging from blindness to spinal paralysis. Caroline Corner of Cantor Fitzgerald follows companies with technologies that can both address dire diseases and reap windfalls for investors. In this interview with The Life Sciences Report, Corner brings important names to investors' attention.(7/29/15) More >
Two hidden biotech gems, one of which could ride the coattails of a U.S.-based product on a very positive regulatory path, top John Hester's list of Australian investments with upside potential. (7/22/15) More >
Learn More About Companies in This Issue
|Alliance for Regenerative Medicine|
BrainStorm Cell Therapeutics Inc.
RepliCel Life Sciences Inc.
|Nobilis Health Corp.|
|Aethlon Medical Inc.|